tadalafil has been researched along with Renal Insufficiency, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, MS; Badary, DM; Hamdy, MM; Sabra, MS | 1 |
| Abd Elkadir, A; Armaly, Z; Artol, S; Farah, R; Ghattas, N; Habashi, N; Jabbour, AR; Kinaneh, S; Nseir, W; Saffouri, A | 1 |
| Hirano, K; Hotta, Y; Kataoka, T; Kimura, K; Maeda, Y; Naiki-Ito, A; Takahashi, S; Tomita, N | 1 |
1 trial(s) available for tadalafil and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients.
Topics: Aged; Carnitine; Cross-Over Studies; Female; Haptoglobins; Humans; Kidney Diseases; Male; Phosphodiesterase 5 Inhibitors; Prospective Studies; Renal Insufficiency, Chronic; Tadalafil | 2019 |
2 other study(ies) available for tadalafil and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats.
Topics: Adenine; Animals; Caspase 3; Furosemide; Humans; Kidney Failure, Chronic; Rats; Renal Insufficiency, Chronic; Tadalafil | 2022 |
The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease.
Topics: Animals; Blood Pressure; Creatinine; Male; Phosphodiesterase 5 Inhibitors; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Inbred Dahl; Renal Insufficiency, Chronic; Tadalafil | 2020 |